PK Flashcards
sides of a hepatocyte
1) basolateral: contact with blood
2) apical: contact with sinusoids
factors affecting drug distribution into hepatocytes
1) perfusion rate limited
- most drugs rapid diffusion from sinusoidal blood into hepatocytes (reach equilibrium fast)
2) permeability rate limited
- for large/polar drugs
what does low Eh mean?
permeability rate limited
what does high Eh mean?
perfusion rate limited
when there is high Eh, what changes when fu changes?
since it is perfusion rate limited, CL and Eh minimally affected by changes in fu
when there is low Eh, what changes when fu changes?
since it is permeability rate limited, CL and Eh are affected by changes in fu
what are the assumptions for well-stirred model
1) once drug enters it is distributed instantaneously since liver is 1 homogenous model so no diffusion delay
equations for CLb, h for well-stirred model
1) high Eh: perfusion rate limited
CLb, h = Qh
2) low Eh: capacity rate limited
CLb, h = fub x CLint
effect of increases in fu on C and Cu for high Eh
C: unchanged because C includes both bound and unbound so total C increases
Cu: increases because more fu and Eh and CLb,h remains the same
effect of increases in fu on C and Cu for low Eh
C: decreased cuz CLb, h and Eh increases so more is cleared
Cu: unchanged because CLb, h and Eh increases accordingly to clear the extra fu
factors affecting renal clearance (CLr) - urine flow
- water extremely reabsorbed -> drug concentrate in urine -> favours reabsorption of drug cuz of concentration gradient
- faster urine flow = lesser time for reabsorption = increase CLr
- only for drugs that are mostly reabsorbed
- diuresis (for poisoning) -> input > fluid -> pass out urine -> excrete drugs
factors affecting renal clearance (CLr) - urine pH
- urine pH = 6.4 (4.4 - 7.9)
- factors that affect pH: forced acidification/alklalinsation, diet, clinical state
- polar/non-polar acid/base drug excreted ionised/unionised depending on pH and pKa
- differences in degree of ionisation for polar drugs
1) very weak acid/base: largely unionised, extensively reabsorbed, low CLr
2) weak acid (moderate-low pKa): CLr sensitive to pH
3) weak base (moderate-high pKa): CLr sensitive to pH, minimally/extensively reabsorbed depending on pH - differences in degree of ionisation for nonpolar drugs
1) not reabsorbed in unionised form so not affected by urine pH
DDI involving metabolism - enzyme inhibition
- increase toxicity
- competitive vs non-competitive inhibition
- reversible (remove perpetuator drug) vs irreversible (need time for body to remove drug) inhibition
- mechanism based/irreversible inactivation: metabolism produce reactive intermediate that irreversibly inactivate enzyme, body need time to produce more enzyme
DDI involving metabolism - enzyme induction
. inducer (perpetuator drug) increases de novo RNA & protein synthesis to generate more CYP
- e.g. enter hepatocyte to bind to/activate nuclear receptors
. inducer stabilise translation/inhibition of protein degradation pathway (2E1)
DDI involving excretion
. glomerular filtration: molecular filtration: competition for protein binding, alterations to renal blood flow
. tubular secretion: active process: compete for active transport
. tubular reabsorption: passive process: alteration in urine pH affect ionisation of drug